KCM
BIIB icon

Kennedy Capital Management’s Biogen BIIB Stock Holding History

Kennedy Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
9,808
+805
+9% +$148K 0.04% 432
2025
Q4 		$1.58M Buy
9,003
+166
+2% +$27.1K 0.03% 443
2025
Q3 		$1.24M Buy
8,837
+4,334
+96% +$586K 0.03% 486
2025
Q2 		$566K Buy
4,503
+52
+1% +$6.48K 0.01% 541
2025
Q1 		$609K Buy
4,451
+56
+1% +$8.01K 0.01% 571
2024
Q4 		$672K Buy
4,395
+815
+23% +$137K 0.01% 624
2024
Q3 		$694K Buy
3,580
+642
+22% +$134K 0.02% 623
2024
Q2 		$681K Buy
2,938
+618
+27% +$134K 0.01% 620
2024
Q1 		$500K Buy
+2,320
New +$543K 0.01% 658

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kennedy Capital Management's BIIB Position: Q1 2026 in Review

Kennedy Capital Management increased its Biogen (BIIB) stake by 8.9% in Q1 2026, buying an estimated $148K and bringing the position to 9,808 shares worth $1.8M. The position accounts for 0.04% of the portfolio, ranked #432.

Kennedy Capital Management first reported a position in BIIB in Q1 2024 and has held it in 9 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Kennedy Capital Management held 9,808 shares of Biogen worth $1.8M as of Q1 2026.
  • Kennedy Capital Management bought 805 Biogen shares in Q1 2026, an estimated $148K.
  • Biogen made up 0.04% of Kennedy Capital Management's portfolio in Q1 2026, its #432 holding.
  • Kennedy Capital Management first reported a position in Biogen in Q1 2024 and has held it in 9 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.